Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl-EPA in Schizophrenia Prodrome
NCT00634361Phase 3Completed
- Sponsor
- Yale University
- Start
- Sep 2001
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Epadel in schizophrenia, sponsored by Yale University. Started Sep 2001; status: completed.
02
Drugs
Epadel
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00634361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634361.